19 May 2013
Keywords: gw, ibs, drug, filed, next, month, glaxo
Article | 20 May 1999
Glaxo Wellcome has reported Phase III trial results with its drug forirritable bowel syndrome, Lotronex (alosetron), and says it plans ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.